ConductScience.org, home

Paper28632002

Management of prostacyclin side effects in adult patients with pulmonary arterial hypertension.

Kingman M and 5 others. Pulm Circ, 2017. Cited by 65 papers, by iCite.

Cite this record

ConductScience Library. Management of prostacyclin side effects in adult patients with pulmonary arterial hypertension. Papers, record 28632002. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28632002

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Management of prostacyclin side effects in adult patients with pulmonary arterial hypertension.
PubMed
Journal
Pulm Circ
PubMed
Year
2017
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
65
iCite
Relative citation ratio, by iCite
3.13
iCite
Revised in PubMed
2020-10-01
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kingman MMartha
2Archer-Chicko CChristine
3Bartlett MMary
4Beckmann JJoy
5Hohsfield RRobin
6Lombardi SSandra

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References36

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17026501The effect of infused prostacyclin in migraine and cluster headache.Headache1981https://conductscience.org/library/papers/7026501PubMed
226748508Comparative Safety and Tolerability of Prostacyclins in Pulmonary Hypertension.Drug Saf2016https://conductscience.org/library/papers/26748508PubMed
326648729The limits of oral therapy in pulmonary arterial hypertension management.Ther Clin Risk Manag2015https://conductscience.org/library/papers/26648729PubMed
415163595Prostacyclin and its analogues in the treatment of pulmonary hypertension.Pharmacol Ther2004https://conductscience.org/library/papers/15163595PubMed
524603117Pharmacokinetics of 3 times a day dosing of oral treprostinil in healthy volunteers.J Cardiovasc Pharmacol2014https://conductscience.org/library/papers/24603117PubMed
615243533Cutaneous findings in patients with pulmonary arterial hypertension receiving long-term epoprostenol therapy.J Am Acad Dermatol2004https://conductscience.org/library/papers/15243533PubMed
724355641Definitions and diagnosis of pulmonary hypertension.J Am Coll Cardiol2013https://conductscience.org/library/papers/24355641PubMed
818378784Prostacyclin therapies for the treatment of pulmonary arterial hypertension.Eur Respir J2008https://conductscience.org/library/papers/18378784PubMed
96270739Prostacyclin stimulates the adenylate cyclase system of human thyroid tissue.Prostaglandins1981https://conductscience.org/library/papers/6270739PubMed
1024618545Subcutaneous treprostinil is well tolerated with infrequent site changes and analgesics.Pulm Circ2013https://conductscience.org/library/papers/24618545PubMed
1124392948Selexipag for the treatment of pulmonary arterial hypertension.Expert Opin Pharmacother2014https://conductscience.org/library/papers/24392948PubMed
1224267307Parenteral and inhaled prostanoid therapy in the treatment of pulmonary arterial hypertension.Clin Chest Med2013https://conductscience.org/library/papers/24267307PubMed
1325602947Advances in therapeutic interventions for patients with pulmonary arterial hypertension.Circulation2014https://conductscience.org/library/papers/25602947PubMed
1420504865Pulmonary arterial hypertension: from the kingdom of the near-dead to multiple clinical trial meta-analyses.Eur Heart J2010https://conductscience.org/library/papers/20504865PubMed
1523231023Optimal use of treprostinil in pulmonary arterial hypertension: a guide to the correct use of different formulations.Drugs2012https://conductscience.org/library/papers/23231023PubMed
1626219978The molecular targets of approved treatments for pulmonary arterial hypertension.Thorax2016https://conductscience.org/library/papers/26219978PubMed
1711120706Prostacyclin analogues differentially inhibit growth of distal and proximal human pulmonary artery smooth muscle cells.Circulation2000https://conductscience.org/library/papers/11120706PubMed
1816389016The efficacy of ginger for the prevention of postoperative nausea and vomiting: a meta-analysis.Am J Obstet Gynecol2006https://conductscience.org/library/papers/16389016PubMed
1917332729Bloodstream infections among patients treated with intravenous epoprostenol or intravenous treprostinil for pulmonary arterial hypertension--seven sites, United States, 2003-2006.MMWR Morb Mortal Wkly Rep2007https://conductscience.org/library/papers/17332729PubMed
2026320113
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).
Eur Heart J2016https://conductscience.org/library/papers/26320113PubMed

See all 36 referencesDownload CSV of references

Cited by45

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 65 citations.

PMIDTitleJournalYearIn PapersSource
42871737
A Team-Based Patient Engagement Approach to Selexipag Initiation and Maintenance in Pulmonary Arterial Hypertension (TEAM PAH): Real-World Dosing Patterns and Persistence Among Patients With and Without a History of Methamphetamine Use.
Pulm Circ2026https://conductscience.org/library/papers/42871737PubMed
42840966Contemporary Economic, Hospitalization, and Mortality Burden Among Pulmonary Arterial Hypertension Patients: A Real-World US Claims Data Analysis.Pulm Circ2026https://conductscience.org/library/papers/42840966PubMed
42808704Real-world analysis on hemodynamic effectiveness and adverse events of selexipag in pulmonary arterial hypertension.Ther Adv Respir Dis2026https://conductscience.org/library/papers/42808704PubMed
42514219Polycythemia Vera, Thrombophilia, CTEPH, Cerebral Venous Sinus Thrombosis and Vertebral Artery Occlusion: A Case-Illustrated Narrative Review of Competing Thrombotic and Hemorrhagic Risks.Life (Basel)2026https://conductscience.org/library/papers/42514219PubMed
42463617Food Effects on the Pharmacokinetics of Single Dose and Steady-State Ralinepag, a Novel Oral Prostacyclin Agonist, in Healthy Volunteers.Am J Cardiovasc Drugs2026https://conductscience.org/library/papers/42463617PubMed
42306238A Phase 2 Study of the Safety and Tolerability of Treprostinil Palmitil Inhalation Powder in Patients With Pulmonary Hypertension Associated With Interstitial Lung Disease.Pulm Circ2026https://conductscience.org/library/papers/42306238PubMed
41860188Endothelial triple-pathway vasorelaxation as an adjunctive strategy in resistant hypertension.J Hypertens2026https://conductscience.org/library/papers/41860188PubMed
41822469
Frostbite in Children: A Case Series and Development of a New Iloprost-Driven Protocol: Les engelures chez les enfants : une série de cas et l'élaboration d'un nouveau protocole faisant appel à l'iloprost.
Plast Surg (Oakv)2026https://conductscience.org/library/papers/41822469PubMed
41579242Advances in and Clinical Experience with Subcutaneous Infusion Pump Therapy for Pulmonary Arterial Hypertension.Adv Ther2026https://conductscience.org/library/papers/41579242PubMed
41437481Use of Sotatercept to Facilitate Transition From Intravenous to Oral Prostacyclin Therapy.Clin Respir J2025https://conductscience.org/library/papers/41437481PubMed
41416907Expert consensus on patient engagement strategies for improving patient activation and shared decision making in pulmonary arterial hypertension.J Am Assoc Nurse Pract2026https://conductscience.org/library/papers/41416907PubMed
41356785Transitioning From Parenteral Prostanoids to Oral Selexipag in Pulmonary Arterial Hypertension: A Multicenter Retrospective Cohort Study.Pulm Circ2025https://conductscience.org/library/papers/41356785PubMed
41229706Case report: Successful use of sotatercept to treat pulmonary arterial hypertension in a patient with hereditary hemorrhagic telangiectasia.Respir Med Case Rep2025https://conductscience.org/library/papers/41229706PubMed
41212478Transitioning Between Treprostinil Formulations: Evidence and Strategies.Adv Ther2026https://conductscience.org/library/papers/41212478PubMed
41160576Start up: A French program to support patients with pulmonary arterial hypertension during the adjustment of prostanoids to the individualized optimal dose.PLoS One2025https://conductscience.org/library/papers/41160576PubMed
41054690The Role of Phosphodiesterase-5 Enzyme Inhibitors and Prostacyclin Analogs in Reactive Pulmonary Vasculopathy in Systolic Heart Failure: A Narrative Review.Cureus2025https://conductscience.org/library/papers/41054690PubMed
41030324Case report: Use of sotatercept to treat pulmonary arterial hypertension in a patient with hereditary hemorrhagic telangiectasia.Respir Med Case Rep2025https://conductscience.org/library/papers/41030324PubMed
40816851Lupus-Associated Pulmonary Arterial Hypertension: A Success Story.JACC Case Rep2025https://conductscience.org/library/papers/40816851PubMed
40567294Hypopituitarism Induced by Continuous Infusion of PGI2 Analogues: A Case Series and the Role of ACTH Screening and Hydrocortisone Treatment.Pulm Circ2025https://conductscience.org/library/papers/40567294PubMed
40322494Updates on Pulmonary Hypertension.Open Respir Med J2025https://conductscience.org/library/papers/40322494PubMed

See all 45 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
PTGIS5740PubTator's text mininghttps://conductscience.org/library/genes/5740

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28632002

GET https://conductscience.org/api/papers/v1/28632002/references?page=2